According to a document submitted to the U.S. Securities and Exchange Commission, as of April 24, 2026, biotechnology company Immuneering Corp observed a median overall survival of 17.3 months in the intent-to-treat population of its 320 mg dosage group.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This data is derived from ongoing company research and has been reported to regulatory authorities as key information. The survival data is an important indicator for evaluating the clinical potential of its candidate therapy, reflecting the median overall survival time of patients receiving this dosage treatment.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Overnight News Summary for June 2
老虎证券•2026/06/01 23:06
The US stock market has increased its market value by 11.7 trillion dollars since March 30.
AiCoin•2026/06/01 22:43
Microchip Technology shares rise due to positive news on data center business revenues
华尔街见闻•2026/06/01 22:21
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$71,265.38
-3.62%
Ethereum
ETH
$1,999.99
-0.76%
Tether USDt
USDT
$0.9986
+0.01%
BNB
BNB
$692.49
-2.48%
XRP
XRP
$1.3
-2.91%
USDC
USDC
$0.9996
-0.00%
Solana
SOL
$81.21
-1.66%
TRON
TRX
$0.3434
-1.99%
Hyperliquid
HYPE
$74.38
+2.45%
Dogecoin
DOGE
$0.1007
+0.16%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now